Page last updated: 2024-08-23

razoxane and Cardiomyopathy, Dilated

razoxane has been researched along with Cardiomyopathy, Dilated in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gisterek, I; Mazur, G; Wróbel, T; Włodarska, I; Zymliński, R; Łacko, A1
Csóka, M; Erdélyi, D; Erlaky, H; Horváth, E; Jókúti, L; Kemény, V; Kovács, G; Müller, J; Szabolcs, J; Tóth, K1
Csóka, M; Erdélyi, D; Erlaky, H; Horváth, E; Jókúti, L; Kovács, GT; Müller, J; Szabolcs, J; Tóth, K1

Reviews

1 review(s) available for razoxane and Cardiomyopathy, Dilated

ArticleYear
[Cardiac toxicity in cancer therapy].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:73

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cardiomyopathy, Dilated; Cardiovascular Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Radiotherapy, Adjuvant; Razoxane; Risk Factors; Sarcoma

2002

Trials

1 trial(s) available for razoxane and Cardiomyopathy, Dilated

ArticleYear
[Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
    Magyar onkologia, 2006, Volume: 50, Issue:1

    Topics: Adolescent; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Child, Preschool; Female; Heart; Humans; Male; Razoxane; Retrospective Studies; Treatment Outcome; Ventricular Function, Left

2006

Other Studies

1 other study(ies) available for razoxane and Cardiomyopathy, Dilated

ArticleYear
Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?
    European journal of pediatrics, 2007, Volume: 166, Issue:11

    Topics: Acute Disease; Anthracyclines; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Female; Heart; Humans; Male; Razoxane; Risk Factors

2007